Market Research Report : Coronary stents market in india 2014 - Sample

  • 267 views
Uploaded on

For the complete report, get in touch with us at: info@netscribes.com …

For the complete report, get in touch with us at: info@netscribes.com

Abstract:
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types - those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.

Table of Contents:

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
267
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
12
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Insert Cover Image using Slide Master View Do not distort Coronary Stents Market – India August 2014
  • 2. 2 Executive Summary Market Drivers & Challenges Competitive Landscape Coronary stents market in India is expected to grow at a CAGR of x1% and x2% in value-terms and volume-terms respectively, over 2012 - 2018e There are three types of coronary stents available in the market, bare metal stents (BMS), drug- eluting stents (DES), and bioabsorbable stents Drivers: Increasing lifestyle based diseases Improving health infrastructure Changing demographics Increased healthcare spending and insurance coverage Advancements in technology and medical procedures Challenges: Problems associated with usage Constant need for innovation and new product development Major Foreign Companies Major Domestic Companies Company 1 Company 2 Company 3 Company 4 Company 5 Company 6 Buyer Details Top Hospitals Buying Coronary Stents in India Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5 Hospital 6 Regulatory Bodies Regulatory Policies Regulatory Processes Government Involvement CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 3. 3 •Macroeconomic Indicators •Introduction •Market Overview •Drivers & Challenges •Government Involvement Regulatory Bodies Regulatory Policies Regulatory Processes •Competitive Landscape •Buyer Details •Recent Developments •Strategic Recommendations •Appendix CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 4. 4 Economic Indicators (1/3) 11 12 13 14 15 INR tn Q4 c4 b4 a4 Q3 c3 b3 a3 Q2 d2 c2 b2 a2 Q1 d1 c1 b1 a1 2010-11 2011-12 2012-13 2013-14 GDP at Factor Cost: Quarterly Inflation Rate: Monthly -2 -1 0 1 2 % Sep 2013 - Oct 2013 p -t Jul 2013 - Aug 2013 Aug 2013 - Sep 2013 Oct 2013 - Nov 2013 q r Nov 2013 - Dec 2013 s CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 5. 5 Market Size and Growth (Value-Wise) Coronary Stents Market – Overview • Indian market for coronary stents is expected to show steady growth in coming years, providing strong opportunities for potential players to earn high revenues and increase their profits • There are three types of coronary stents available in the market, bare metal stents, drug-eluting stents and bioabsorbable stents • Type 1 stents experience the highest demand while Type 2 stents are still at a nascent stage Indian market for coronary stents is poised to grow in the coming years with emphasis on drug-eluting stents Market Size and Growth (Volume-Wise) 0 10 20 30 40 50 g3% g2% g1% 2016e b1% 2012 a a2% a1% d3% d2% d1% 2014e c c3% f f3% f2% f1% 2015e d 2017e g c2% c1% 2013 b b3% b2% INR bn x1% 2018e h h3% h2% h1% Type 1 Type 2 Type 3 0 200 400 600 800 2014e r r3% r2% r1% 2013 x2% 2018e v v3% v2% v1% 2017e u u3% u2% u1% 2016e t t3% p2% t2% p1% ‘000 q q3%q 2% q1% 2012 p t1% 2015e s s3% s2% s1% Type 1 Type 2 Type 3 CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 6. 6 Coronary Stents – Price Trends Prices vary not only across stent types but also depending on whether it is indigenously manufactured or is foreign made Type of stent Indigenous /Foreign Price (INR) Remarks Bare Metal Indigenous •These are price at which distributors purchase from manufacturers •When hospitals procure stents directly from manufacturers, they can get up to ‘x’% discounts Bare Metal Foreign •Price at which distributors supply the stents to hospitals •Difficult for hospitals to procure directly from manufacturers as these stents are manufactured outside India Drug-Eluting Indigenous •Price at which distributors purchase from manufacturers •Hospitals can get discounts on these price by purchasing directly from the manufacturer Drug-Eluting Foreign •Price to the end-user, that is, the patients •Distributors can procure the lower priced, foreign made DES for as little as INR ‘a’ Bioabsorbable Foreign •Was priced INR ‘u’ when it was launched in Dec 2012 •Presently, Abbott has monopoly on these stents but in future as more companies produce these stents, the price is expected to fall CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 7. 7 Drivers & Challenges – Summary Drivers Increasing lifestyle based diseases Improving health infrastructure Changing demographics Increased healthcare spending and insurance coverage Advancements in technology and medical procedures Challenges Problems associated with usage Constant need for innovation and new product development CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 8. 8 Regulation of medical devices such as stents are done through different divisions under the MoHFW Organizational Structure Level 1 Level 2 Level 3 Level 4 Level 5 Level 6A Level 7B Level 6B Level 7A Level 7D Level 7C CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 9. 9 Although there isn’t any specific legislation governing the entire medical devices industry, certain devices are… Regulatory Body A •Regulatory Body A is the main body for the regulation of pharmaceuticals and medical devices in India •Within Regulatory Body A, Entity B is responsible for the regulating pharmaceuticals and medical devices and is advised by Body C and Body D •It is responsible for establishing the safety, efficacy, and quality standards for pharmaceuticals and medical devices •A list of regulated pharmaceuticals and devices, Indian Pharmacopeia, is published and updated by Regulatory Body A •It also appoints notified bodies for conducting conformity assessment procedures including tests for all drug and device applications to ensure that it complies with all standards set by the body •Regulatory Body A is also divided into several zonal offices which conduct the pre-licensing and post-licensing inspections, post-market surveillance, and recalls whenever necessary •Apart from the regulatory functions, Regulatory Body A also offers technical guidance and trains regulatory officials and analysts as well as monitors adverse events •Regulatory Body A also works with the World Health Organization to promote Good Manufacturing Practice (GMP) Regulatory Bodies (1/2) CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 10. 10 Competitive Rivalry Bargaining Power of Suppliers Bargaining Power of Buyers Threat of Substitutes Threat of New Entrants Impact Impact Impact Impact Impact Market Competition – Porter’s Five Forces Analysis CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 11. 11 Market for coronary stents in India is dominated by products from foreign companies Market Share – Volume-Wise (2013) b% a% c% f% d% h% g% Company 5 Company 3 Company 2 Company 4 Company 1 Company 6 Others Competition Overview CORONARY STENTS MARKET IN INDIA 2014.PPT •MNCs have a dominant share in the coronary stents market in India • Products from MNCs are generally viewed as superior to those manufactured by domestic companies • As a result of this, there is a higher uptake of products from foreign companies while Indian manufacturers find it difficult to get buyers for their products • Company 1, company 2 and Company 3 together account for ~’m’% of the market in terms of volume and ‘n’% of the market in terms of value • Company 1 is the clear leader in the market with a a% share in volume terms in 2013 compared to p% in 2012 • Company 2 with a market share of b% had the second-largest share
  • 12. 12 Key Ratios of Top 3 Companies – Operational Basis (FY 2013) (1/3) Competitive Benchmarking – Private Companies (1/4) 0 10 20 30 40 50 a1 b2 Company 2 b1 Company 1 a2 a3 Company 3 % b3 Operating Margin Net Margin • Company 3 recorded operating margin of a3%, higher than that of Company 2 and Company 1 which recorded operating margin of a2% and a1% respectively • Net margin was highest for Company 2 which recorded a net margin of b2%, followed by Company 1 and Company 3 which recorded net margin of b1% and b3% respectively CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 13. 13 Key People Products and Services Company Information Offices and Centres – India Corporate Address Tel No. Fax No. Website Year of Incorporation Ticker Symbol Stock Exchange Category Products/Services Medical Equipment Interventional Devices Name Designation Person 1 Chairman and Managing Director Person 2 Director Person 3 Director Person 4 Independent Director Head Office CORONARY STENTS MARKET IN INDIA 2014.PPT Public: Domestic Company – Company 1 (1/5)
  • 14. 14 Key Ratios Financial Summary • Company earned a net profit of INR XX mn in FY 20XX, as compared to net profit of INR Y mn in FY 20YY • It reported total Income of INR XX mn in FY 20XX, registering an increase of X per cent over FY 20YY • It earned an operating margin of X.X per cent in FY 20XX an increase of X.X percentage points over FY 20YY • The company reported debt to equity ratio of X.XX in FY 20XX, an increase of X.X per cent over FY 20YY Particulars y-o-y change (2013-12) 2013 2012 2011 2010 Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Improved Decline Financial Snapshot Total Income Net Profit / Loss 6 4 2 0 25 20 15 10 5 0 INR bn INR bn 2013 a4 b4 2012 a3 b3 2011 a2 b2 2010 a1 b1 Financial Summary Indicators Value (dd/mm/yyyy) Market Capitalization (INR bn) Total Enterprise Value (INR bn) EPS (INR) PE Ratio (Absolute) CORONARY STENTS MARKET IN INDIA 2014.PPT Public: Domestic Company – Company 1 (2/5)
  • 15. 15 Key Business Segments Key Geographic Segments Business Highlights Description News Overview • Company 1 is a medical device company specializing in vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies • It has ‘n’ subsidiaries across Country 1, Country 2, Country 3 and Country 4 Network • It markets its products in over ‘m’ countries with significant presence in Region 1, region 2 and Region 3 Design and R&D • It has design and development facilities in City 1, Country A; City 2 and City 3, Country B; and City 4, Country C 30,000 20,000 10,000 0 2013 c1 b1 a1 30,000 20,000 10,000 0 2013 b2 a2 Segment 1 Segment 2 Segment 3 Region 1 Region 2 CORONARY STENTS MARKET IN INDIA 2014.PPT Key Business Segments data is not available for financial years before 2013 Key Geographic Segments data is not available for financial years before 2013 Public: Domestic Company – Company 1 (3/5)
  • 16. 16 Business Highlights Description News OEM Partnerships •Company 1 partners with leading medical companies around the world and manufactures white-label products Manufacturing Locations •It has 3 manufacturing units each in Country 1 and country 2 and six units in Country 3 •In Country 3 , it has two manufacturing units each at City 1 and City 2, and one each at City 3, City 4 and City 5 •In mid 2012, the company acquired ‘k’ acres of land from the Organization A at the industrial growth centre in City 5 to set up a greenfield manufacturing facility with an investment of INR ‘p’ bn •Three group companies of Company 1 will have their manufacturing facility here and they were expected to be ready by the end of 2013 Coronary Stents Products •Coronary stents from the company are manufactured by Company A which is a wholly- owned subsidiary of Company B and is part of the Company 1 group •Stainless steel and cobalt chromium bare metal stents from the company include the ‘Model 1’, ‘Model 2’, ‘Model 3’ and ‘Model 4’ stents •It also markets ‘Model 5’ series of polymer-free DES which are coated with Paclitaxel and are available on stainless steel and cobalt chromium platforms •‘Model 6’ coronary stent system is the company’s latest cobalt chromium coronary stent technology from the ‘Y’ series and is delivered by the company’s Paclitaxel-eluting coronary balloon dilatation catheter ‘Model A’ CORONARY STENTS MARKET IN INDIA 2014.PPT Public: Domestic Company – Company 1 (4/5)
  • 17. 17 T O W S CORONARY STENTS MARKET IN INDIA 2014.PPT Public: Domestic Company – Company 1 – SWOT Analysis (5/5)
  • 18. 18 Key People Products and Services Company Information Offices and Centres – India Corporate Address Tel No. Fax No. Website Year of Incorporation Products/Services es Name Designation Person 1 Director Person 2 Director Person 3 Director Head Office CORONARY STENTS MARKET IN INDIA 2014.PPT Private: Foreign Company – Company 2 (1/5)
  • 19. 19 Name No. of Shares held Shareholder 1 Shareholder 2 Total 100.00% Category 1 Shareholders of the Company as on dd/mm/yy Ownership Structure CORONARY STENTS MARKET IN INDIA 2014.PPT Private: Foreign Company – Company 2 (2/5)
  • 20. 20 Financial Snapshot Key Ratios Financial Summary • Company earned a net profit of INR XX mn in FY 20XX, as compared to net profit of INR Y mn in FY 20YY • It reported total Income of INR XX mn in FY 20XX, registering an increase of X per cent over FY 20YY • It earned an operating margin of X.X per cent in FY 20XX an increase of X.X percentage points over FY 20YY • The company reported debt to equity ratio of X.XX in FY 20XX, an increase of X.X per cent over FY 20YY Improved Decline Total Income Net Profit / Loss 5 -15 0 -5 -10 -20 -25 30 25 20 15 10 5 0 INR bn INR bn 2013 a4 b4 2012 a3 b3 2011 a2 b2 2010 a1 b1 Particulars y-o-y change (2013-12) 2013 2012 2011 2010 Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Note: Financial year ending 31st Dec CORONARY STENTS MARKET IN INDIA 2014.PPT Private: Foreign Company – Company 2 (3/5)
  • 21. 21 Business Highlights Description News Overview •Company 2 operates in the nutritional products, laboratory diagnostics, medical devices, and pharmaceutical therapies space •It was previously the domestic formulations business of Company A and was renamed as Company 2 after it was acquired by Company B in May 2010 Manufacturing Facility •It has a formulation facility at City 1, State 1 where a wide range of formulations and dosage forms are manufactured •However, coronary stents sold by the company in India are manufactured by various subsidiaries of the parent company Company B Coronary Stents Products •A number of models of coronary stents from the company are available in India •‘Model 1’ Carotid Stent System and ‘Model 2’ Coronary Stent marketed by the company are manufactured by Company C, Country 1 •‘Model 3’ Coronary Stent System and ‘Model 4’ series are manufactured by Company D, Country 2 •‘Model 5’ Stent System is manufactured by Company E in its manufacturing facility at City 3, Country 3 •Everolimus Eluting ‘Model 6’, ‘Model 7’, ‘Model 8’, ‘Model 9’, ‘Model 10’ and ‘Model 11’ are manufactured by Company F, Country 4 •‘Model 12’ stent system are manufactured by Company G, Country 5 •In 20xx, ‘Model 13’, a Type A stent from the company, was launched in India at a price of INR ‘y’ mn; however the price was decreased to INR ‘z’ mn within 6 months due to the overwhelming response that it received CORONARY STENTS MARKET IN INDIA 2014.PPT Private: Foreign Company – Company 2 (4/5)
  • 22. 22 T O W S CORONARY STENTS MARKET IN INDIA 2014.PPT Private: Foreign Company – Company 2 – SWOT Analysis (4/5)
  • 23. 23 Hospital Name Hospital Logo Hospital Chain Ownership Type Angioplasty Procedures Per Month All India Institute of Medical Sciences Max Super Specialty Hospital Asian Heart Institute B.M. Birla Heart Research Centre Apollo Hospital# Sri Jayadeva Institute of Cardiology Narayana Hrudayalaya Fortis Healthcare* Wockhardt Hospital** Metro Heart Institute Top 10 hospitals buying coronary stents in India Buyer Snapshot: List of Top 10 Buyers of Coronary Stents CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 24. 24 Key People Products and Services Company Information Corporate Address Tel No. Fax No. Website Year of Incorporation Name Designation Person 1 President (Institute Body) Person 2 Dean Person 3 Director Person 4 Medical Superintendent Category Products/Services Specialty Centers Surgery Laboratory Head Office and Hospital Network– India Public: Domestic Company – Hospital 1 (1/3) Head Office Hospital Network CORONARY STENTS MARKET IN INDIA 2014.PPT
  • 25. 25 Description News Overview •Hospital 1 is a group of 7 hospitals across India •It has ‘m’ teaching departments and centers, a total of ‘p’ beds, ‘q’ doctors (including faculty members, senior and junior residents) and ‘r’ nurses Facilities •It is a leader in stem cell therapy, especially in the fields of cardiology and neurology •It has India's first and only minimally invasive surgery training centre, under collaboration with Germany •It is a pioneer of robotic surgeries in India, particularly the Da Vinci system for urology, and robotic CTVS •The first in-vitro fertilization facility in the public sector was set up at the Hospital in Feb 2008 Future Plans •Expansion plans of the hospital were recently approved by the Regulatory Body A •The government is planning to set up two more such hospitals cum institutions at City 1, State 1 and City 2, State 2 Business Highlights CORONARY STENTS MARKET IN INDIA 2014.PPT Public: Domestic Company – Hospital 1 (2/3)
  • 26. 26 Parameter Hospital Indicators Total cardiac patients per month Angioplasties per month Stent providers Purchase decision factors Stents procurement Centralized/ Hospital level Contact details HOD/ Technician/ Procurement Procedure/ process involved in procurement Contact details – Purchase Stent types Overview of Stent Procurement Process CORONARY STENTS MARKET IN INDIA 2014.PPT Public: Domestic Company – Hospital 1 (3/3)
  • 27. 27 Thank you for the attention About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives. Coronary Stents Market – India report is part of Netscribes’ Healthcare Series. For any queries or customized research requirements, contact us at: Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. Phone: +91 22 4098 7600 E-Mail: info@netscribes.com CORONARY STENTS MARKET IN INDIA 2014.PPT